Moderate to severe acquired brain injury (ABI) can cause a series of functional (e.g., neuromotor, neuropsychological and psycho-behavioural) sequelae, which require a complex neuro-rehabilitative process, as well as - with increasing of the ABI severity - a constant assistance by at least one informal caregiver.
In particular, emotional and behavioural sequelae of ABI are widely reported, and their presence and persistence often have deleterious effects on recovery and rehabilitation outcomes, especially in the long-term (e.g., in relation to family and social reintegration and return to work).
Many important variables (e.g., ABI neuro-pathology and severity, pre-and post-injury personality variables, environmental variables, etc.) may account for the different development and expression of such symptoms.
However, some relevant methodological issues should be taken into account, such as the diagnostic classification adopted, the limited applicability of traditional diagnostic tools, and the influence of neurological and cognitive symptoms, as well as the impairment in self-awareness.
The main aims of the current Research Topic are: a) to progress the understanding of the underlying causes to the main emotional and behavioural sequelae of ABI; b) to address the relevant issue on how assessing them at best; c) to study the mechanisms underlying novel promising treatments; and d) to study all possible pharmacological and non-pharmacological effective approach to these disorders.
This Research Topic calls for all types of articles (Original Research, Methods, Reviews, Protocols, etc.) that cover, but are not restricted to, the following points in the field of moderate and severe ABI:
- Possible individual differences in emotional and behavioural sequelae;
- Modelling emotional and behavioural comorbidities, such as cognitive deficits;
- Neuroimaging evidences of emotional and behavioural sequelae;
- Pharmacotherapy of emotional and behavioural sequelae.
- Novel neuropsychological interventions to address emotional and behavioural sequelae.
- Neuromodulation to treat emotional and behavioural sequelae
- Identification and effectiveness of non-pharmacological treatment of these emotional and behavioural sequelae, including neuropsychological, behavioural and psychotherapeutic approaches, as well as intervention with relatives/caregivers
Moderate to severe acquired brain injury (ABI) can cause a series of functional (e.g., neuromotor, neuropsychological and psycho-behavioural) sequelae, which require a complex neuro-rehabilitative process, as well as - with increasing of the ABI severity - a constant assistance by at least one informal caregiver.
In particular, emotional and behavioural sequelae of ABI are widely reported, and their presence and persistence often have deleterious effects on recovery and rehabilitation outcomes, especially in the long-term (e.g., in relation to family and social reintegration and return to work).
Many important variables (e.g., ABI neuro-pathology and severity, pre-and post-injury personality variables, environmental variables, etc.) may account for the different development and expression of such symptoms.
However, some relevant methodological issues should be taken into account, such as the diagnostic classification adopted, the limited applicability of traditional diagnostic tools, and the influence of neurological and cognitive symptoms, as well as the impairment in self-awareness.
The main aims of the current Research Topic are: a) to progress the understanding of the underlying causes to the main emotional and behavioural sequelae of ABI; b) to address the relevant issue on how assessing them at best; c) to study the mechanisms underlying novel promising treatments; and d) to study all possible pharmacological and non-pharmacological effective approach to these disorders.
This Research Topic calls for all types of articles (Original Research, Methods, Reviews, Protocols, etc.) that cover, but are not restricted to, the following points in the field of moderate and severe ABI:
- Possible individual differences in emotional and behavioural sequelae;
- Modelling emotional and behavioural comorbidities, such as cognitive deficits;
- Neuroimaging evidences of emotional and behavioural sequelae;
- Pharmacotherapy of emotional and behavioural sequelae.
- Novel neuropsychological interventions to address emotional and behavioural sequelae.
- Neuromodulation to treat emotional and behavioural sequelae
- Identification and effectiveness of non-pharmacological treatment of these emotional and behavioural sequelae, including neuropsychological, behavioural and psychotherapeutic approaches, as well as intervention with relatives/caregivers